newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock

AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported that on July 21, 2023, AgeX and Juvenescence Limited entered into an Exchange